Hangzhou Coco Healthcare Products Co.,Ltd.
Simbol: 301009.SZ
SHZ
9.21
CNYTržna cena danes
89.9693
Razmerje P/E
0.0000
Razmerje PEG
2.50B
Kapaciteta MRK
- 0.00%
Donos DIV
Hangzhou Coco Healthcare Products Co.,Ltd. (301009-SZ) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 863.1 | 689.5 | 884 | |||||||
balance-sheet.row.short-term-investments | 0 | -20.4 | -21.2 | -23.5 | |||||||
balance-sheet.row.net-receivables | 0 | 213 | 274.5 | 188.2 | |||||||
balance-sheet.row.inventory | 0 | 114.8 | 182.4 | 153.9 | |||||||
balance-sheet.row.other-current-assets | 0 | 13.9 | 12.2 | 27.6 | |||||||
balance-sheet.row.total-current-assets | 0 | 1204.7 | 1158.5 | 1253.8 | |||||||
balance-sheet.row.property-plant-equipment-net | 0 | 663.4 | 670.4 | 694.8 | |||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.intangible-assets | 0 | 82.5 | 84.9 | 87 | |||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 82.5 | 84.9 | 87 | |||||||
balance-sheet.row.long-term-investments | 0 | 30.1 | 21.5 | 23.7 | |||||||
balance-sheet.row.tax-assets | 0 | 10.1 | 8.2 | 2.1 | |||||||
balance-sheet.row.other-non-current-assets | 0 | 1.2 | 5.2 | 24.2 | |||||||
balance-sheet.row.total-non-current-assets | 0 | 787.3 | 790.1 | 831.8 | |||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-assets | 0 | 1992 | 1948.6 | 2085.6 | |||||||
balance-sheet.row.account-payables | 0 | 439 | 429.9 | 528.5 | |||||||
balance-sheet.row.short-term-debt | 0 | 6.2 | 1.4 | 1.5 | |||||||
balance-sheet.row.tax-payables | 0 | 5.5 | 6.5 | 1.4 | |||||||
balance-sheet.row.long-term-debt-total | 0 | 11.9 | 3.3 | 5.1 | |||||||
Deferred Revenue Non Current | 0 | 45.2 | 39.1 | 6.8 | |||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||
balance-sheet.row.other-current-liab | 0 | 0.6 | 0.8 | 0.6 | |||||||
balance-sheet.row.total-non-current-liabilities | 0 | 57.1 | 42.3 | 11.9 | |||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.capital-lease-obligations | 0 | 11.9 | 3.3 | 5.1 | |||||||
balance-sheet.row.total-liab | 0 | 542.4 | 516.9 | 578.6 | |||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.common-stock | 0 | 271.9 | 271.9 | 271.9 | |||||||
balance-sheet.row.retained-earnings | 0 | 300.4 | 284.3 | 348.8 | |||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 73.2 | 70.8 | |||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 800.4 | 723.2 | 723.2 | |||||||
balance-sheet.row.total-stockholders-equity | 0 | 1372.7 | 1352.6 | 1414.7 | |||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1992 | 1948.6 | 2085.6 | |||||||
balance-sheet.row.minority-interest | 0 | 76.9 | 79.2 | 92.3 | |||||||
balance-sheet.row.total-equity | 0 | 1449.6 | 1431.8 | 1507 | |||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||
Total Investments | 0 | 9.7 | 0.3 | 0.3 | |||||||
balance-sheet.row.total-debt | 0 | 18.1 | 4.6 | 6.6 | |||||||
balance-sheet.row.net-debt | 0 | -845 | -684.8 | -877.4 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -56.2 | 39.4 | 223.1 | ||||||
cash-flows.row.depreciation-and-amortization | 0 | 61.3 | 49.4 | 39.2 | ||||||
cash-flows.row.deferred-income-tax | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.stock-based-compensation | 0 | 6.1 | -3.8 | 3.6 | ||||||
cash-flows.row.change-in-working-capital | 0 | -110.7 | -53.8 | 67.3 | ||||||
cash-flows.row.account-receivables | 0 | -31 | 114.1 | -101.2 | ||||||
cash-flows.row.inventory | 0 | -40.2 | -34 | 4.5 | ||||||
cash-flows.row.account-payables | 0 | -33.5 | -137.7 | 167.6 | ||||||
cash-flows.row.other-working-capital | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.other-non-cash-items | 0 | 68.5 | 15.4 | 66.2 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.acquisitions-net | 0 | 0.6 | 25 | 0.1 | ||||||
cash-flows.row.purchases-of-investments | 0 | -65 | -95 | -150.3 | ||||||
cash-flows.row.sales-maturities-of-investments | 0 | 65.2 | 220.1 | 51.1 | ||||||
cash-flows.row.other-investing-activites | 0 | 3.4 | -24.5 | 8.3 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -112.1 | -114.9 | -311.5 | ||||||
cash-flows.row.debt-repayment | 0 | 0 | -149.1 | -80.6 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | -19 | -0.9 | -23.6 | ||||||
cash-flows.row.other-financing-activites | 0 | -30.8 | 833.8 | 132.7 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -49.9 | 683.8 | 28.5 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 4.2 | -2.6 | -11.6 | ||||||
cash-flows.row.net-change-in-cash | 0 | -195 | 616.8 | 101.2 | ||||||
cash-flows.row.cash-at-end-of-period | 0 | 639.5 | 834.4 | 217.6 | ||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 834.4 | 217.6 | 116.4 | ||||||
cash-flows.row.operating-cash-flow | 0 | -37.2 | 50.5 | 395.9 | ||||||
cash-flows.row.capital-expenditure | 0 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.free-cash-flow | 0 | -153.6 | -189.9 | 175.1 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1081.5 | 1186.3 | 1186.4 | |||||||
income-statement-row.row.cost-of-revenue | 0 | 890.6 | 1030.9 | 965.3 | |||||||
income-statement-row.row.gross-profit | 0 | 190.9 | 155.4 | 221.1 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.operating-expenses | 0 | 175.2 | 171.3 | 176.8 | |||||||
income-statement-row.row.cost-and-expenses | 0 | 1065.7 | 1202.2 | 1142.1 | |||||||
income-statement-row.row.interest-income | 0 | 24.2 | 23.3 | 12.6 | |||||||
income-statement-row.row.interest-expense | 0 | 0.7 | 0.3 | 1 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.total-operating-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.interest-expense | 0 | 0.7 | 0.3 | 1 | |||||||
income-statement-row.row.depreciation-and-amortization | 0 | 56.8 | 61.3 | 49.4 | |||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||
income-statement-row.row.operating-income | 0 | 20.2 | -55.5 | 45.3 | |||||||
income-statement-row.row.income-before-tax | 0 | 19.5 | -56.4 | 43.5 | |||||||
income-statement-row.row.income-tax-expense | 0 | 1.7 | -0.1 | 4.1 | |||||||
income-statement-row.row.net-income | 0 | 20.2 | -43.1 | 39.7 |
Pogosto zastavljeno vprašanje
Kaj je Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) skupna sredstva?
Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) skupna sredstva so 1992017074.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.187.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 0.539.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.026.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.028.
Kaj je Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 20184911.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 18052009.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 175169142.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.